56.23 0.00 (0.00%)
After hours: 4:33PM EDT
|Bid||55.89 x 800|
|Ask||60.00 x 900|
|Day's Range||55.89 - 56.86|
|52 Week Range||33.93 - 59.40|
|Beta (3Y Monthly)||0.73|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.35 (0.62%)|
|1y Target Est||N/A|
We are upbeat about solid contributions from Boston Scientific's (BSX) Cardiovascular business group, which comprises Interventional Cardiology and Peripheral Interventions.
Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine and an upbeat second quarter 2019 view are likely to fuel Stryker's (SYK) Q2 earnings. However, forex might be a woe.
Within Covance Drug Development, LabCorp (LH) is focused on driving profitable growth through expanded solutions and enhanced operational capabilities.
Solid global demand, substantial impact from the electron microscopy business and robust volume growth and productivity are likely to favor Thermo Fisher's (TMO) analytical instruments revenues.
Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner's (CERN) Q2 earnings. However, expected decline in bookings is likely to be a dampener.
Probable revenue growth in APAC and EMEA regions and higher Oncology revenues are likely to aid Varian Medical (VAR) in Q3 earnings. However, contraction in margins might be a dampener.
Quest Diagnostics' (DGX) frequent partnership wins with health care leaders and sensible buyouts are creating bountiful opportunities for the top and the bottom line.
Patterson Companies (PDCO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.
DENTSPLY SIRONA Inc NASDAQ/NGS:XRAYView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for XRAY with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting XRAY. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.98 billion over the last one-month into ETFs that hold XRAY are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Monday started with a jolt for investors in the pharmaceutical distributor, which announced in a regulatory filing that longtime Chief Financial Officer Jorge Gomez is leaving the company.
Dental products maker Dentsply Sirona Inc. said Monday it has appointed Jorge Gomez, former chief financial officer of Cardinal Health Inc. as its CFO. The announcement came shortly after Cardinal Health said Gomez was leaving on Aug. 9. Dentsply shares were not active premarket, but have gained 55% in 2019, while the S&P 500 has gained 19.3%.
With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.